Please use this identifier to cite or link to this item:
標題: Expression of VP1 protein in the milk of transgenic mice: A potential oral vaccine protects against enterovirus 71 infection
作者: Chen, H.L.
Huang, J.Y.
Chu, T.W.
Tsai, T.C.
Hung, C.M.
Lin, C.C.
Liu, F.C.
Wang, L.C.
Chen, Y.J.
Lin, M.F.
Chen, C.M.
關鍵字: enterovirus 71;VP1 capsid protein;transgenic mice;animal model;oral;vaccine;antiviral infection;poliomyelitis-like disease;central-nervous-system;mouth-disease;methylotrophic yeast;type-71 infections;immune-responses;lethal;challenge;pichia-pastoris;neonatal mice;foot
Project: Vaccine
期刊/報告no:: Vaccine, Volume 26, Issue 23, Page(s) 2882-2889.
Enterovirus 71 (EV71) is the most common etiological agent detected in cases of hand-foot-and-mouth disease (HFMD) resulting in incidences of neurological complications and fatality in recent years. The clinical data have already shown the significant increase in recent EV71 epidemic activity throughout the Asia-Pacific region. Due to the lack of an effective antiviral agent, primary prevention of the disease, including the development of an effective vaccine, has been the top priority in terms of control strategies. In this study, we first generated a transgenic animal system to produce the EV71 VP1 capsid protein under the control of alpha-lactalbumin promoter and a-casein leader sequences. A high level of recombinant VP1 protein (2.51 mg/ml) was expressed and secreted into the milk of transgenic mice. Mouse pups that received VP1-transgenic milk orally demonstrated relatively better health conditions after challenge with the respective virus as compared with the non-transgenic milk fed group; moreover, the mice fed with the VP1-milk had body weights similar to those of the PBS placebo control groups. According to the serum-neutralization assay and serum antibody detection, the littermates suckling VP1-milk generated antibodies specific to EV71. Our data suggest that EV71 VP1-containing milk is suitable for development as a potential oral vaccine. (c) 2008 Elsevier Ltd. All rights reserved.
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.03.041
Appears in Collections:生命科學系所

Show full item record

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.